A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device
|
|||||
       
 |
The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes 
Two biotechnology and health technology companies are discovering precision treatments for neurological disorders with simulation models for individual patients. . . . → Read More: AI-Aided Collaboration to Discover Neuro Disease Drugs 
A software company is partnering with a psychologist to explore virtual reality working with mindfulness for relieving pain in cancer patients. . . . → Read More: Virtual Reality Studied for Chronic Cancer Pain 
Researchers in Europe and the U.S. are investigating gut processes in pigs to reduce antibiotics commonly used against infections, a source of antibiotic resistance. . . . → Read More: Intl. Team Studying Antibiotic Overuse in Pigs 
A collaboration between developers of protein analytics and test-strip diagnostics aims to create a quicker, more sensitive, easy-to-use Covid-19 detection test. . . . → Read More: Partnership Developing Faster, Sensitive Covid-19 Test  Comments are closed  Joint ventures/collaborations, New products  biomedical, biotechnology, cancer, chemistry, Covid-19, engineering, life sciences, medical device, merger, physical sciences, U.K. 
Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership. . . . → Read More: Ginkgo Acquires Bayer Agricultural Biologics Technology Comments are closed Joint ventures/collaborations agriculture, biotechnology, chemistry, energy, Europe, genomics, life sciences, physical sciences 
A developer of new treatments for the inherited lung disease cystic fibrosis emerged from stealth mode, raising $111 million in new venture funds. . . . → Read More: Cystic Fibrosis Start-Up Raises $111M in New Funds One comment - (Comments are closed) Finance, Joint ventures/collaborations, New products biomedical, biotechnology, challenge, chemistry, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, physical sciences, university, venture capital 
A developer of therapies from engineered microbes is collaborating with a synthetic biology components company on tools to create engineered gut bacteria. . . . → Read More: Synthetic Bio Companies Partner on Therapeutic Microbes Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, life sciences, mathematics, pharmaceuticals, physical sciences 
A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics. . . . → Read More: Biotech, Synthetic Bio Companies Partner on T-Cell Therapies 2 comments - (Comments are closed) Joint ventures/collaborations, New products Asia, biomedical, biotechnology, cancer, entrepreneurs, genomics, life sciences, pharmaceuticals, preclinical, university |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
